GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (NSE:AARTIDRUGS) » Definitions » PB Ratio

Aarti Drugs (NSE:AARTIDRUGS) PB Ratio : 2.55 (As of Apr. 19, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Aarti Drugs PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-19), Aarti Drugs's share price is ₹357.45. Aarti Drugs's Book Value per Share for the quarter that ended in Dec. 2024 was ₹139.96. Hence, Aarti Drugs's PB Ratio of today is 2.55.

Good Sign:

Aarti Drugs Ltd stock PB Ratio (=2.35) is close to 5-year low of 2.35.

The historical rank and industry rank for Aarti Drugs's PB Ratio or its related term are showing as below:

NSE:AARTIDRUGS' s PB Ratio Range Over the Past 10 Years
Min: 1.86   Med: 3.57   Max: 11.27
Current: 2.55

During the past 13 years, Aarti Drugs's highest PB Ratio was 11.27. The lowest was 1.86. And the median was 3.57.

NSE:AARTIDRUGS's PB Ratio is ranked worse than
64.16% of 932 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs NSE:AARTIDRUGS: 2.55

During the past 12 months, Aarti Drugs's average Book Value Per Share Growth Rate was 6.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 12.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 19.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 19.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Aarti Drugs was 26.60% per year. The lowest was 9.50% per year. And the median was 17.70% per year.

Back to Basics: PB Ratio


Aarti Drugs PB Ratio Historical Data

The historical data trend for Aarti Drugs's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs PB Ratio Chart

Aarti Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.79 7.08 3.83 2.62 3.12

Aarti Drugs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.12 - 3.67 -

Competitive Comparison of Aarti Drugs's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Drugs's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Drugs's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Drugs's PB Ratio distribution charts can be found below:

* The bar in red indicates where Aarti Drugs's PB Ratio falls into.


;
;

Aarti Drugs PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Aarti Drugs's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=357.45/139.958
=2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Aarti Drugs  (NSE:AARTIDRUGS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Aarti Drugs PB Ratio Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Drugs Business Description

Traded in Other Exchanges
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.

Aarti Drugs Headlines

No Headlines